Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Irl790
2. N-(2-(3-fluoro-5-methylsulfonylphenoxy)ethyl)propan-1-amine
1. Irl790
2. Irl-790
3. Hd4qv8gx26
4. 1403894-72-3
5. N-[2-(3-fluoro-5-methylsulfonylphenoxy)ethyl]propan-1-amine
6. 1-propanamine, N-(2-(3-fluoro-5-(methylsulfonyl)phenoxy)ethyl)-
7. Mesdopetam [inn]
8. Unii-hd4qv8gx26
9. Mesdopetam [who-dd]
10. Chembl4594447
11. Schembl13732678
12. Gtpl10811
13. Hy-109150
14. Cs-0115974
15. N-[2-(3-fluoro-5-methylsulfonyl-phenoxy)ethyl]propan-1-amine
16. N-{2-[3-fluoro-5-(methylsulfonyl)phenoxy]ethyl}-n-propylamine
| Molecular Weight | 275.34 g/mol |
|---|---|
| Molecular Formula | C12H18FNO3S |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 275.09914277 g/mol |
| Monoisotopic Mass | 275.09914277 g/mol |
| Topological Polar Surface Area | 63.8 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 329 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Mesdopetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mesdopetam, including repackagers and relabelers. The FDA regulates Mesdopetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mesdopetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mesdopetam supplier is an individual or a company that provides Mesdopetam active pharmaceutical ingredient (API) or Mesdopetam finished formulations upon request. The Mesdopetam suppliers may include Mesdopetam API manufacturers, exporters, distributors and traders.
Mesdopetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mesdopetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mesdopetam GMP manufacturer or Mesdopetam GMP API supplier for your needs.
A Mesdopetam CoA (Certificate of Analysis) is a formal document that attests to Mesdopetam's compliance with Mesdopetam specifications and serves as a tool for batch-level quality control.
Mesdopetam CoA mostly includes findings from lab analyses of a specific batch. For each Mesdopetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mesdopetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Mesdopetam EP), Mesdopetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mesdopetam USP).
LOOKING FOR A SUPPLIER?
